Xyosted 100 MG/0.5 ML auto-INJ 0.5ML
Ended Awarded
- Contract number
- SPE2DR26FQP8H
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $9,466
Award facts
- Contract value 100% obligated
- $9,466.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $9,466.20 to AmerisourceBergen Drug Corp for the supply of Xyosted 100 mg/0.5 mL auto-injectors on November 12, 2025, with completion scheduled for November 13, 2025. This competitively awarded, firm fixed-price delivery order was issued without a set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Xyosted is a testosterone replacement therapy delivered via subcutaneous auto-injector, commonly prescribed for treatment of hypogonadism in military and veteran populations served by the Defense Health Agency.
This delivery order represents a child contract executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. As a major pharmaceutical distributor and critical vendor within the federal medical supply chain, AmerisourceBergen supplies a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The company's extensive federal contract portfolio demonstrates consistent capability in meeting competitive federal procurement requirements across multiple therapeutic domains, supporting defense and veteran healthcare systems globally.
Quick answers
Who was awarded contract SPE2DR26FQP8H?
SPE2DR26FQP8H was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 12, 2025.
How much is contract SPE2DR26FQP8H worth?
The government has obligated $9,466 on SPE2DR26FQP8H.
Is contract SPE2DR26FQP8H an order under another contract?
Yes. SPE2DR26FQP8H is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQP8H competed?
The extent of competition for SPE2DR26FQP8H was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award